TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

PURPOSE: We previously reported a dose-finding and phase II trial of the TI-CE regimen (paclitaxel [T] plus ifosfamide [I] followed by high-dose carboplatin [C] plus etoposide [E] with stem-cell support) in germ cell tumor (GCT) patients predicted to have a poor prognosis with conventional-dose salv...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Feldman, Darren R., Sheinfeld, Joel, Bajorin, Dean F., Fischer, Patricia, Turkula, Stefan, Ishill, Nicole, Patil, Sujata, Bains, Manjit, Reich, Lilian M., Bosl, George J., Motzer, Robert J.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Clinical Oncology 2010
विषय:
Original Reports
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3651604/
https://ncbi.nlm.nih.gov/pubmed/20194867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.1561
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन